• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

抗体募集分子:一种新兴的范式,用于调节免疫功能以治疗人类疾病。

Antibody-recruiting molecules: an emerging paradigm for engaging immune function in treating human disease.

机构信息

Department of Chemistry, Yale University, New Haven, Connecticut 06520, United States.

出版信息

ACS Chem Biol. 2012 Jul 20;7(7):1139-51. doi: 10.1021/cb300119g. Epub 2012 Jul 3.

DOI:10.1021/cb300119g
PMID:22758917
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3401898/
Abstract

Synthetic immunology, the development of synthetic systems capable of modulating and/or manipulating immunological functions, represents an emerging field of research with manifold possibilities. One focus of this area has been to create low molecular weight synthetic species, called antibody-recruiting molecules (ARMs), which are capable of enhancing antibody binding to disease-relevant cells or viruses, thus leading to their immune-mediated clearance. This article provides a thorough discussion of contributions in this area, beginning with the history of small-molecule-based technologies for modulating antibody recognition, followed by a systematic review of the various applications of ARM-based strategies. Thus, we describe ARMs capable of targeting cancer, bacteria, and viral pathogens, along with some of the scientific discoveries that have resulted from their development. Research in this area underscores the many exciting possibilities at the interface of organic chemistry and immunobiology and is positioned to advance both basic and clinical science in the years to come.

摘要

合成免疫学,即开发能够调节和/或操纵免疫功能的合成系统,是一个具有多种可能性的新兴研究领域。该领域的一个重点是创造能够增强抗体与疾病相关细胞或病毒结合的低分子量合成物质,称为抗体募集分子(ARM),从而导致其免疫介导的清除。本文全面讨论了这一领域的贡献,首先介绍了基于小分子的调节抗体识别的技术历史,然后系统地综述了基于 ARM 的策略的各种应用。因此,我们描述了能够靶向癌症、细菌和病毒病原体的 ARM,以及由此产生的一些科学发现。该领域的研究强调了有机化学和免疫生物学界面的许多令人兴奋的可能性,并有望在未来几年推动基础科学和临床科学的发展。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f9ec/3401898/06f8c2da5a29/nihms391218f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f9ec/3401898/1650db6e2aa2/nihms391218f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f9ec/3401898/90dd3ad9dd86/nihms391218f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f9ec/3401898/fea6a263697e/nihms391218f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f9ec/3401898/9409921999a8/nihms391218f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f9ec/3401898/06f8c2da5a29/nihms391218f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f9ec/3401898/1650db6e2aa2/nihms391218f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f9ec/3401898/90dd3ad9dd86/nihms391218f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f9ec/3401898/fea6a263697e/nihms391218f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f9ec/3401898/9409921999a8/nihms391218f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f9ec/3401898/06f8c2da5a29/nihms391218f5.jpg

相似文献

1
Antibody-recruiting molecules: an emerging paradigm for engaging immune function in treating human disease.抗体募集分子:一种新兴的范式,用于调节免疫功能以治疗人类疾病。
ACS Chem Biol. 2012 Jul 20;7(7):1139-51. doi: 10.1021/cb300119g. Epub 2012 Jul 3.
2
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.系统性药理学治疗慢性斑块状银屑病:网络荟萃分析。
Cochrane Database Syst Rev. 2021 Apr 19;4(4):CD011535. doi: 10.1002/14651858.CD011535.pub4.
3
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.慢性斑块状银屑病的全身药理学治疗:一项网状Meta分析。
Cochrane Database Syst Rev. 2020 Jan 9;1(1):CD011535. doi: 10.1002/14651858.CD011535.pub3.
4
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.慢性斑块状银屑病的全身药理学治疗:一项网状荟萃分析。
Cochrane Database Syst Rev. 2017 Dec 22;12(12):CD011535. doi: 10.1002/14651858.CD011535.pub2.
5
Systemic treatments for metastatic cutaneous melanoma.转移性皮肤黑色素瘤的全身治疗
Cochrane Database Syst Rev. 2018 Feb 6;2(2):CD011123. doi: 10.1002/14651858.CD011123.pub2.
6
Antiretroviral therapy (ART) for treating HIV infection in ART-eligible pregnant women.用于治疗符合抗逆转录病毒治疗条件的孕妇艾滋病毒感染的抗逆转录病毒疗法。
Cochrane Database Syst Rev. 2010 Mar 17(3):CD008440. doi: 10.1002/14651858.CD008440.
7
Comparison of cellulose, modified cellulose and synthetic membranes in the haemodialysis of patients with end-stage renal disease.纤维素、改性纤维素和合成膜在终末期肾病患者血液透析中的比较。
Cochrane Database Syst Rev. 2001(3):CD003234. doi: 10.1002/14651858.CD003234.
8
A systematic review of adult-onset clinically amyopathic dermatomyositis (dermatomyositis siné myositis): a missing link within the spectrum of the idiopathic inflammatory myopathies.成人起病的临床无肌病性皮肌炎(无肌性皮肌炎)的系统评价:特发性炎性肌病谱系中的缺失环节
J Am Acad Dermatol. 2006 Apr;54(4):597-613. doi: 10.1016/j.jaad.2005.10.041. Epub 2006 Jan 23.
9
Psychological interventions for adults who have sexually offended or are at risk of offending.针对有性犯罪行为或有性犯罪风险的成年人的心理干预措施。
Cochrane Database Syst Rev. 2012 Dec 12;12(12):CD007507. doi: 10.1002/14651858.CD007507.pub2.
10
Neuraminidase inhibitors for preventing and treating influenza in healthy adults and children.用于预防和治疗健康成人及儿童流感的神经氨酸酶抑制剂。
Cochrane Database Syst Rev. 2012 Jan 18;1:CD008965. doi: 10.1002/14651858.CD008965.pub3.

引用本文的文献

1
Chemical tools to study and modulate glycan-mediated host-bacteria interactions.用于研究和调节聚糖介导的宿主-细菌相互作用的化学工具。
Curr Opin Chem Biol. 2025 Jun 4;87:102603. doi: 10.1016/j.cbpa.2025.102603.
2
Antibiotics re-booted-time to kick back against drug resistance.抗生素迎来新契机——是时候反击耐药性了。
NPJ Antimicrob Resist. 2025 May 30;3(1):47. doi: 10.1038/s44259-025-00096-1.
3
Harnessing endogenous anti-glycan antibodies using a novel, bifunctional immunotherapy to treat gram-negative bacterial infections.

本文引用的文献

1
Polyvalent Interactions in Biological Systems: Implications for Design and Use of Multivalent Ligands and Inhibitors.生物系统中的多价相互作用:对多价配体和抑制剂设计与应用的启示
Angew Chem Int Ed Engl. 1998 Nov 2;37(20):2754-2794. doi: 10.1002/(SICI)1521-3773(19981102)37:20<2754::AID-ANIE2754>3.0.CO;2-3.
2
Reprogramming urokinase into an antibody-recruiting anticancer agent.将尿激酶重编程为一种招募抗体的抗癌剂。
ACS Chem Biol. 2012 Feb 17;7(2):316-21. doi: 10.1021/cb200374e. Epub 2011 Nov 18.
3
Monoclonal antibodies in infectious diseases: clinical pipeline in 2011.
利用一种新型双功能免疫疗法来利用内源性抗聚糖抗体治疗革兰氏阴性细菌感染。
J Immunol. 2025 Jul 1;214(7):1617-1629. doi: 10.1093/jimmun/vkaf055.
4
Antibody-Recruiting Surfaces Using Adaptive Multicomponent Supramolecular Copolymers.使用适应性多组分超分子共聚物的抗体招募表面
Biomacromolecules. 2025 May 12;26(5):2971-2985. doi: 10.1021/acs.biomac.5c00043. Epub 2025 Apr 9.
5
Redirecting the host immune response to bacterial infection with antibody-recruiting molecules (ARMs).利用抗体招募分子(ARMs)重定向宿主对细菌感染的免疫反应。
Curr Opin Chem Biol. 2025 Jun;86:102585. doi: 10.1016/j.cbpa.2025.102585. Epub 2025 Mar 20.
6
Siderophore-based targeted antibody recruitment for promoting immune responses towards Gram-negative pathogens.基于铁载体的靶向抗体募集以促进针对革兰氏阴性病原体的免疫反应。
RSC Chem Biol. 2025 Jan 16;6(3):387-393. doi: 10.1039/d4cb00293h. eCollection 2025 Mar 5.
7
A platform for mapping reactive cysteines within the immunopeptidome.免疫肽组中反应性半胱氨酸的作图平台。
Nat Commun. 2024 Nov 8;15(1):9698. doi: 10.1038/s41467-024-54139-8.
8
Recruiting the Immune System against Pathogenic Bacteria Using High-Affinity Chimeric Tags.利用高亲和力嵌合标签招募免疫系统对抗致病细菌
Bioconjug Chem. 2024 Nov 20;35(11):1716-1722. doi: 10.1021/acs.bioconjchem.4c00291. Epub 2024 Oct 14.
9
Targeted recruitment of immune effector cells for rapid eradication of influenza virus infections.靶向招募免疫效应细胞以快速清除流感病毒感染。
Proc Natl Acad Sci U S A. 2024 Oct 8;121(41):e2408469121. doi: 10.1073/pnas.2408469121. Epub 2024 Sep 30.
10
The effect of Fc region affinity of protein-based antibody-recruiting molecules on antibody-dependent cellular cytotoxicity.基于蛋白质的抗体招募分子的Fc区域亲和力对抗体依赖性细胞毒性的影响。
RSC Adv. 2024 Jul 22;14(32):22860-22866. doi: 10.1039/d4ra03391d. eCollection 2024 Jul 19.
传染病中的单克隆抗体:2011 年的临床研发管线。
Infect Dis Clin North Am. 2011 Dec;25(4):789-802. doi: 10.1016/j.idc.2011.07.006.
4
Vaccines for the twenty-first century society.二十一世纪的疫苗。
Nat Rev Immunol. 2011 Nov 4;11(12):865-72. doi: 10.1038/nri3085.
5
Prostate-specific membrane antigen as a potential novel vascular target for treatment of glioblastoma multiforme.前列腺特异性膜抗原作为治疗多形性胶质母细胞瘤的潜在新型血管靶点。
Arch Pathol Lab Med. 2011 Nov;135(11):1486-9. doi: 10.5858/arpa.2010-0740-OA.
6
Antiviral drugs for viruses other than human immunodeficiency virus.抗其他病毒药物(不包括人类免疫缺陷病毒)。
Mayo Clin Proc. 2011 Oct;86(10):1009-26. doi: 10.4065/mcp.2011.0309.
7
A chemically induced vaccine strategy for prostate cancer.化学诱导疫苗策略治疗前列腺癌。
ACS Chem Biol. 2011 Nov 18;6(11):1223-31. doi: 10.1021/cb200222s. Epub 2011 Sep 21.
8
Antitumor efficacy of a thrombospondin 1 mimetic CovX-body.CovX 体模拟血小板反应蛋白 1 的抗肿瘤疗效。
Transl Oncol. 2011 Aug;4(4):249-57. doi: 10.1593/tlo.11136. Epub 2011 Aug 1.
9
Loss of CD4 T-cell-dependent tolerance to proteins with modified amino acids.氨基酸修饰蛋白的 CD4 T 细胞依赖性耐受丧失。
Proc Natl Acad Sci U S A. 2011 Aug 2;108(31):12821-6. doi: 10.1073/pnas.1110042108. Epub 2011 Jul 18.
10
Folate hydrolase (prostate-specific membrane [corrected] antigen) 1 expression in bladder cancer subtypes and associated tumor neovasculature.膀胱癌亚型中叶酸水解酶(前列腺特异性膜抗原)1 的表达及其与肿瘤新生血管的关系。
Mod Pathol. 2011 Nov;24(11):1521-9. doi: 10.1038/modpathol.2011.112. Epub 2011 Jul 1.